I'm LongbridgeAI, I can summarize articles.Jefferies analyst David Stanton has maintained a Buy rating on Monash IVF Group Ltd (MVF) with a price target of A$0.90. The current analyst consensus for the company is a Moderate Buy, with an average price target of A$0.80. Stanton, who focuses on the Healthcare sector, has an average return of 15.0% and a success rate of 45.19% on his stock recommendations.
In a report released today, David Stanton from Jefferies maintained a Buy rating on Monash IVF Group Ltd, with a price target of A$0.90.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Stanton covers the Healthcare sector, focusing on stocks such as Cochlear , CSL, and Telix Pharmaceuticals. According to TipRanks, Stanton has an average return of 15.0% and a 45.19% success rate on recommended stocks.
Currently, the analyst consensus on Monash IVF Group Ltd is a Moderate Buy with an average price target of A$0.80.